{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:40:22Z","timestamp":1789609222483,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1053\/j.seminhematol.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T02:42:07Z","timestamp":1523414527000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies"],"prefix":"10.1053","volume":"55","author":[{"given":"Sonata","family":"Jodele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"10.1053\/j.seminhematol.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bmt.2017.39","article-title":"Transplant-associated thrombotic microangiopathy: opening Pandora\u2019s box","volume":"52","author":"Gavriilaki","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.critrevonc.2016.09.004","article-title":"An overview of hematopoietic stem cell transplantation related thrombotic complications","volume":"107","author":"Sahin U","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib4","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","author":"Khosla","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JBM.S102235","article-title":"Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment","volume":"7","author":"Rosenthal","year":"2016","journal-title":"J Blood Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.04.003_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.pcl.2013.02.007","article-title":"Advances in critical care of the pediatric hematopoietic stem cell transplant patient","volume":"60","author":"Chima","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"10.1053\/j.seminhematol.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MPH.0000000000000401","article-title":"Intensive care unit admissions among children after hematopoietic stem cell transplantation: incidence, outcome, and prognostic factors","volume":"37","author":"Fernandez-Garcia","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hon.2310","article-title":"Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study","volume":"35","author":"Ye","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib10","first-page":"275825","article-title":"Acute ventricular wall thickening: sepsis, thrombotic microangiopathy, or myocarditis?","volume":"2015","author":"De Schryver","year":"2015","journal-title":"Case Rep Cardiol"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40620-016-0345-y","article-title":"Renal dysfunction following bone marrow transplantation","volume":"30","author":"Kemmner","year":"2017","journal-title":"J Nephrol"},{"issue":"9","key":"10.1053\/j.seminhematol.2018.04.003_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2018.04.003_bib13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.seminhematol.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1053\/j.seminhematol.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.bbmt.2014.07.008","article-title":"Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation","volume":"20","author":"Laskin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.seminhematol.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1111\/petr.12450","article-title":"Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition","volume":"19","author":"Sakamoto","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.seminhematol.2018.04.003_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.bbmt.2013.07.017","article-title":"Pulmonary hypertension after hematopoietic stem cell transplantation","volume":"19","author":"Dandoy","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbmt.2014.09.028","article-title":"Abnormal echocardiography seven days after stem cell transplant may be an early indicator of thrombotic microangiopathy","volume":"21","author":"Dandoy","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.seminhematol.2018.04.003_bib23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.seminhematol.2018.04.003_bib24","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2018.04.003_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26566","article-title":"Double trouble: complement-mediated thrombotic microangiopathy in patients with hemoglobinopathies after stem cell transplantation","volume":"64","author":"Jodele","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1053\/j.seminhematol.2018.04.003_bib26","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2018.04.003_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2018.04.003_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation","author":"Horv\u00e1th","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.seminhematol.2018.04.003_bib30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2018.04.003_bib31","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2018.04.003_bib32","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1053\/j.seminhematol.2018.04.003_bib33","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/bloodadvances.2017008250","article-title":"In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy","volume":"1","author":"Rotz","year":"2017","journal-title":"Blood Adv"},{"issue":"23","key":"10.1053\/j.seminhematol.2018.04.003_bib34","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood-2015-02-629683","article-title":"Modified Ham test for atypical hemolytic uremic syndrome","volume":"125","author":"Gavriilaki","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2018.04.003_bib35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2018.04.003_bib36","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3324\/haematol.2011.061051","article-title":"Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease","volume":"97","author":"Andrulis","year":"2012","journal-title":"Haematologica"},{"issue":"30","key":"10.1053\/j.seminhematol.2018.04.003_bib37","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1200\/JCO.2013.54.4056","article-title":"Single-nucleotide polymorphisms within the thrombomodulin gene (THBD) predict mortality in patients with graft-versus-host disease","volume":"32","author":"Rachakonda","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2018.04.003_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.seminhematol.2018.04.003_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2018.04.003_bib41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/trf.12859","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options","volume":"55","author":"Kim","year":"2015","journal-title":"Transfusion"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.04.003_bib43","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/bmt.2016.253","article-title":"Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?","volume":"52","author":"Dhakal","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1053\/j.seminhematol.2018.04.003_bib45","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","article-title":"Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.12202","article-title":"Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy","volume":"161","author":"Peffault de Latour","year":"2013","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.seminhematol.2018.04.003_bib47","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"de Fontbrune","year":"2015","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.seminhematol.2018.04.003_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2016.87","article-title":"Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy","volume":"51","author":"Vasu","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2018.04.003_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1076029615599439","article-title":"Eculizumab in transplant-associated thrombotic microangiopathy","volume":"23","author":"Dhakal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"10.1053\/j.seminhematol.2018.04.003_bib50","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.bbmt.2017.08.019","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation: a comparison of eculizumab therapy and conventional therapy","volume":"23","author":"Bohl","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1053\/j.seminhematol.2018.04.003_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/bloodadvances.2016002832","article-title":"Use of the complement inhibitor Coversin to treat HSCT-associated TMA","volume":"1","author":"Goodship","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.04.003_bib52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2018.04.003_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25016","article-title":"Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria","author":"Risitano","year":"2018","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2018.04.003_bib54","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3324\/haematol.2016.153312","article-title":"Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome","volume":"102","author":"Yuan","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.seminhematol.2018.04.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2014.06.007","article-title":"Complement blockade with a C1 esterase inhibitor in paroxysmal nocturnal hemoglobinuria","volume":"42","author":"DeZern","year":"2014","journal-title":"Exp Hematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196318300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196318300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:25:38Z","timestamp":1758522338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196318300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0037196318300106"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2018.04.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}